<DOC>
	<DOC>NCT00365183</DOC>
	<brief_summary>The goals of this study are: - to determine if the combination of two drugs, motexafin gadolinium and pemetrexed, may be an effective treatment for patients with non-small cell lung cancer (NSCLC) who have had one previous chemotherapy regimen that included a platinum containing drug such as cisplatin or carboplatin. - to assess response to treatment in patients with NSCLC six months after beginning study treatment.</brief_summary>
	<brief_title>Trial of Motexafin Gadolinium and Pemetrexed (AlimtaÂ®) for Second Line Treatment in Patients With Non-Small Cell Lung Cancer</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma, Non-Small-Cell Lung</mesh_term>
	<mesh_term>Motexafin gadolinium</mesh_term>
	<mesh_term>Pemetrexed</mesh_term>
	<criteria>18 years or older Stage IIIb, metastatic, or recurrent NSCLC patients who have received one prior platinumbased chemotherapy regimen ECOG performance status score of 0 or 1 Laboratory values indicating inadequate function of bone marrow, liver, or kidneys Symptomatic or uncontrolled brain metastases Evidence of meningeal metastasis &gt; 1 prior regimen (not counting adjuvant or neoadjuvant cytotoxic chemotherapy if completed &gt; 12 months prior to regiment) Medical condition that would increase risk if treated with motexafin gadolinium or impair ability to complete study procedures and assessments</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2013</verification_date>
	<keyword>Non Small Cell Lung Cancer</keyword>
	<keyword>Lung Cancer</keyword>
	<keyword>Metastatic Lung Cancer</keyword>
	<keyword>Inoperable Lung Cancer</keyword>
	<keyword>Advanced Lung Cancer</keyword>
	<keyword>Large Cell Lung Cancer</keyword>
	<keyword>Adenocarcinoma, lung</keyword>
	<keyword>Squamous Cell Carcinoma, lung</keyword>
	<keyword>Squamous Cell Lung Cancer</keyword>
	<keyword>Large Cell Carcinoma, lung</keyword>
	<keyword>Cancer of the Lung</keyword>
	<keyword>Carcinoma</keyword>
	<keyword>Bronchogenic</keyword>
</DOC>